Navigation Links
More grapes, less wrath: Hybrid antimicrobial protein protects grapevines from pathogen
Date:2/21/2012

LOS ALAMOS, New Mexico, February 20, 2012A team of researchers has found a way to ensure that your evening glass of wine will continue to be available, despite the potential attack of Xylella fastidiosa (Xf), a bacterium that causes Pierce's Disease and poses a significant threat to the California wine industry's valuable grapevines.

Researchers from Los Alamos National Laboratory (LANL), University of California at Davis (UCD), and the U.S. Department of Agriculture's Agricultural Research Service have created specially engineered grapevines that produce a hybrid antimicrobial protein that can block Xf infection.

Their research is published in the current edition of Proceedings of the National Academy of Sciences, "An engineered innate immune defense protects grapevines from Pierce's disease," by Abhaya M. Dandekar, et al. The article's online tracking number is 2011-16027R in the PNAS Early Edition to be published the week of Feb. 20, 2012.

By helping the vine fight the microbe with specific proteins, the scientists envision vineyards requiring less reliance on chemicals as growers seek to fend off the bacterium and the glassy-winged sharpshooter (Homalodisca vitripennis) insect that carries it. As the insect feeds on various plants, it distributes the microbe widely.

The key to the project's success is the fact that early in an Xf infection, molecules on the outer membrane of the microbe interact with cells of the grapevine. By interfering with that interaction between microbe and vine, scientists can help the vines block the disease and go on to produce a healthy crop of grapes.

"One thing got us started: with almost any pathogen, the major problem is drug resistance," said Goutam Gupta, the corresponding author of the PNAS paper. "We wanted the plant to clear itself of the pathogen before it is infected, much as the body's immune system naturally recognizes a pathogen and takes action to defeat it."

To make the effective protein, researchers fused two genes: one that encodes a protein to cut a specific molecule on the outer membrane of Xf, and another that triggers the bursting of the Xf bacterium's outer wall, called lysis.

The team inserted the hybrid gene into grapevines and observed the plants' response to Xf infection. "The hybrid protein apparently creates pores in the membrane of the Gram-negative bacterium, Xf," said Gupta, thus allowing the plant to fight back the infection. Sap from the engineered plants successfully killed Xf in laboratory tests, and the whole plants did not exhibit symptoms of Pierce's disease after exposure to the Xf bacterium.

The antimicrobial gene may also protect other economically important plants from Xf-related diseases, and a similar strategy may be effective against a broad range of pathogen-induced plant and human diseases, Gupta said. X. fastidiosa is implicated in oleander leaf scorch, phony peach disease, plum leaf scald, almond leaf scorch, Pierce's disease in grapes, and citrus X disease in Brazil.


'/>"/>

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory
Source:Eurekalert  

Related biology news :

1. New hybrid plants could prompt more prodigious pepper production in Southwest
2. Hybrid vehicle rebates produce scant environmental benefits, high cost
3. Rice researchers make graphene hybrid
4. Single gene dramatically boosts yield, sweetness in tomato hybrids, CSHL-Israeli study finds
5. Genetic key discovered to dramatically increase yields and improve taste of hybrid tomato plants
6. Liposome-hydrogel hybrids: No toil, no trouble for stronger bubbles
7. What causes hybrid vigor?
8. ISU researchers develop hybrid protein tools for gene cutting and editing
9. Hard-wired for chocolate and hybrid cars? How genetics affect consumer choice
10. If GMO genes escape, how will the hybrids do?
11. Potential hemlock hybrids tolerant to invasive hemlock woolly adelgid
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More grapes, less wrath: Hybrid antimicrobial protein protects grapevines from pathogen
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017   Capricor Therapeutics, Inc. ... biotechnology company developing first-in-class biological therapies for cardiac ... has elected to terminate its license agreement with ... agonists, including Cenderitide. "Our decision to ... we prioritize our efforts to advance our core ...
(Date:2/16/2017)... UCHealth ( Aurora, Colorado ) ... nodule patient management. In addition to optimizing care coordination ... the lung, UCHealth looks to improve provider workflow by ... Stephanie Brown, RN , Thoracic Nurse Navigator, ... an Excel spreadsheet, which was extremely arduous and susceptible ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed ... Chin, professor and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 ... 55-year-old practicing female physician suffering from degenerative disc disease with radiculomyelopathy, as a ...
(Date:2/16/2017)... NEW YORK , Feb. 16, 2017 ... $7M Series B financing, adding an additional $3M from ... by Mesa Verde Venture Partners and other strategic partners ... directed towards further accelerating commercial adoption of their flagship ... test and expanding the Paradigm cancer registry. ...
Breaking Biology Technology: